Underweight (BMI ≤18.5), n. (%) |
9 (10 %) |
Normal weight (BMI >8.5 <25), n. (%) |
49 (55
%) |
Overweight (BMI ≥25 ≤30), n. (%) |
26 (29 %) |
Obese (BMI >30), n. (%) |
5 (6 %) |
Diabetes Mellitus, n. (%) |
1 (9 %) |
Dyslipidemia, n. (%) |
11 (12 %) |
Tot-Cholesterol/HDL, mean ±SD |
3.3 ±1.0 |
Framingham risk score, mean ±SD |
3.7 ±2.9 |
Previous smokers, n (%) |
5 (6 %) |
Arterial Hypertension, n (%) |
8 (7 %) |
Active patients with disease activity index ≥3 ESSG, n. (%) |
24 (27
%) |
Erythrocyte Sedimentation Rate (mm/h), mean±SD |
19 ± 14 |
C-Reactive Protein (mg/l), mean±SD |
4.3 ± 5 |
Limited cutaneous SSc, n. (%) |
74 (83 %) |
Interstitial lung disease, n. (%) |
51 (57 %) |
Esophageal Involvement, n. (%) |
79 (89 %) |
Bowel incontinence, n. (%) |
2 (3 %) |
Active digital ulcers, n. (%) |
18 (20 %) |
Digital pitting scars, n. (%) |
55 (62 %) |
Calcinosis, n. (%) |
79 (89 %) |
Renal Involvement, n. (%) |
5 (6 %) |
Pulmonary Arterial Hypertension, n. (%) |
7 (8 %) |
Capillaroscopy scleroderma pattern, n. (%) |
Early 6 (7
%) |
|
Active 49 (55 %) |
|
Late 34 (38 %) |